Navigation Links
Aethlon Medical, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
Date:2/11/2013

NEW YORK, Feb. 11, 2013 /PRNewswire/ -- Aethlon Medical, Inc. (OTC: AEMD), announced today that their February 7th RetailInvestorConferences.com presentation is now available for on-demand viewing.

LINK:  www.retailinvestorconferences.com> red "register/ watch event now" button

Aethlon Medical's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the "virtual trade booth" for the next three weeks.

About Aethlon Medical

Aethlon Medical creates innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of devices the rapid, yet selective removal of disease promoting particles from the entire circulatory system.  At present, The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer, and a medical device being developed under a 5-year contract with Defense Advanced Research Projects Agency (DARPA) to reduce the incidence of sepsis in combat-injured soldiers.  For more information, please visit www.aethlonmedical.com.

About The Aethlon Hemopurifier®

The Aethlon Hemopurifier® is a first-in-class medical device that selectively targets the rapid clearance of infectious viral pathogens and immunosuppressive proteins from the entire circulatory system.  In the treatment of Hepatitis C virus (HCV), human studies have demonstrated that Hemopurifier® therapy may improve immediate, rapid and sustained virologic response rates when administered in the first few days of standard-of-care drug therapy. In addition to accelerating viral load depletion, post-treatment analysis of the
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Aethlon Medical (AEMD) Note: Since September 30th, 2011 / Thank You Shareholders
2. Aethlon Medical Discloses CEO Interview
3. Aethlon Medical (AEMD) Note: Extracorporeal Methods to Reduce Inflammation in Sepsis
4. Aethlon Medical To Present Today At The 15th International Conference On Dialysis
5. Aethlon Medical Announces the Appointment of Laszlo Radvanyi, Ph.D. to its Scientific Advisory Board
6. Aethlon Medical (AEMD) Note: A Medical Device Strategy to Address Metastatic Melanoma
7. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
8. Aethlon Medical Discloses MD Anderson Cancer Center Presentation
9. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
10. Aethlon Medical Announces Renewal of DARPA Dialysis-Like Therapeutics Contract
11. Aethlon Medical Announces the Appointment of Thomas V. Wornham and Philip A. Ward to its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  MGC Diagnostics Corporation (NASDAQ: ... medical technology company, today scheduled a conference call to ... fiscal year 2013, ended April 30, 2013. The call ... 30, 2013. The Company will report financial results for ... markets close on Thursday, May 30, 2013. ...
(Date:5/23/2013)... 2013  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: ... based on intellectual property developed and owned by ... foremost medical research center, today announced that its ... funding from the Israeli Ministry of Industry and ... support product development and advance clinical trials. Cell ...
(Date:5/23/2013)... Calif. , May 23, 2013 Anthem ... program that would have required them to obtain their ... by Consumer Watchdog and Whatley Kallas LLC.  ... Superior Court, alleged that Blue Cross,s mandatory mail order ... threatening their health and privacy. "This settlement ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 2Blue Cross To Allow HIV/AIDS Patients to "Opt-Out" of Mandatory Mail-Order Rx Drug Program, Announces Consumer Watchdog 3
(Date:5/24/2013)... NY (PRWEB) May 24, 2013 The ... is happy to announce that it has donated $10,000 to ... the women held captive in Cleveland, Ohio. , “When the ... Jesus, Michelle Knight, and Amanda Berry and her daughter had ... a decade, we were shocked and horrified,” said Integrative Nutrition ...
(Date:5/24/2013)... more than half of recommended well-child visits had up ... who attended most of their visits, according to a ... Managed Care . The study included more than 20,000 ... with chronic conditions like asthma and heart disease were ... visits, according to the study. In fact, children ...
(Date:5/24/2013)... 2013 The Icahn School of Medicine ... exclusive license rights to commercially develop cardiomyocyte progenitors ... These cells are capable of further differentiation into the ... cells, and vascular smooth muscle cells, and thus could ... tissue. , The original agreement announced in May 2009 ...
(Date:5/24/2013)... -- Nearly three out of four pregnant women ... but these issues don,t significantly affect their quality ... from Loyola University Medical Center in Maywood, Ill., ... physiological and hormonal changes that occur during pregnancy. ... can play a role. The study authors added ...
(Date:5/24/2013)... May 24, 2013 Just about any bodyweight ... Mike Whitfield, a trainer based in Dallas, GA that uses ... there’s one pushup that is not used enough. , “The ... make the standard pushup more challenging. By keeping your hands ... and the abs are being worked much harder than a ...
Breaking Medicine News(10 mins):Health News:Integrative Nutrition Donates $10,000 to the Cleveland Courage Fund 2Health News:Young children who miss well-child visits are more likely to be hospitalized 2Health News:Young children who miss well-child visits are more likely to be hospitalized 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 2Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 3Health News:Icahn School of Medicine at Mount Sinai Grants Exclusive License to Cellular Dynamics International for Development of a Cellular Therapy for Cardiac Muscles 4Health News:Bowel Issues Affect 3 Out of 4 Pregnant Women 2Health News:Medicine Ball Pushups, a Unique Bodyweight Chest Exercise, Released in Video from BodyweightTorch.com 2
... Thoracic Society has released a new official clinical policy ... pulmonary and critical care patients. The statement replaces ATS ... medications and treatment approaches, as well as provides an ... the January 1, 2011, issue of the American ...
... Eighth Annual Chronic Total Occlusion Summit and Left ... featuring state-of-the-art technologies, research findings and new developments ... optimize success in chronic total coronary occlusions and ... summit will include:, When and why to ...
... young women reach adulthood, their mothers can play a key ... vaccine, new research suggests. A study found that college-aged ... HPV vaccine if they had talked to their mother about ... factor in whether young women were vaccinated," said Janice Krieger, ...
... are a major complication in strabismus surgery. Amniotic membrane ... adhesions by forming a biological barrier during healing. In ... Journal of AAPOS , the Official Publication of ... team of researchers from Cairo University have discovered that ...
... (Boston) - Researchers from Boston University School of Medicine ... risk-adjusted percent time in therapeutic range (TTR) should be ... control and thus improve patient outcomes. These findings appear ... and Outcomes . Oral anticoagulation with warfarin is ...
... The pen may be mightier than the scale when it comes ... of snacks and meals is one of the best methods used ... management and diabetes specialist at Greenwich Hospital in Greenwich, Conn. ... you lose [weight] if you do it consistently," he said in ...
Cached Medicine News:Health News:ATS issues statement on the treatment of pulmonary fungal infections 2Health News:ATS issues statement on the treatment of pulmonary fungal infections 3Health News:ATS issues statement on the treatment of pulmonary fungal infections 4Health News:Mothers key to college-age women receiving HPV vaccine 2Health News:Use of amniotic membrane may cause complications in strabismus surgery 2Health News:Researchers measure quality of care in oral anticoagulation 2
Inquire...
Inquire...
... wall of the serum tube is specially ... activate the coagulation process. Serum / gel ... base of the tube; during centrifugation, this ... serum and the blood cells. In the ...
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
Medicine Products: